Systemic cytokine response following exercise-induced muscle damage in humans

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 6, 2009, Pages 777-782

  Philippou, Anastassios ^a   Bogdanis, Gregory ^b   Maridaki, Maria ^b   Halapas, Antonis ^a   Sourla, Antigone ^c   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Endo/Oncoresearch Laboratory   (Greece)

Author keywords

Cytokines; Interleukin 6 (IL 6); Muscle damage; Osteoprotegerin (OPG); Receptor activator of nuclear factor kB ligand (RANKL)

Indexed keywords

INTERLEUKIN 6; LACTATE DEHYDROGENASE; MYOGLOBIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CYTOKINE PRODUCTION; ECCENTRIC MUSCLE CONTRACTION; EXERCISE; HUMAN; HUMAN EXPERIMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; THIGH; TORQUE;

ADULT; EXERCISE; HUMANS; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; OSTEOPROTEGERIN; RANK LIGAND; TIME FACTORS;

EID: 67650600623     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.163     Document Type: Article

References (32)

1. Proske U, Morgan DL. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 2001;537:333-45.
2. Friden J, Lieber RL. Evidence for muscle attachment at relatively long lengths in tendon transfer surgery. J Hand Surg wAmx 1998;23:105-10.
3. Morgan DL, Allen DG. Early events in stretch-induced muscle damage. J Appl Physiol 1999;87:2007-15.
4. Philippou A, Maridaki M, Bogdanis GC. Angle-specific impairment of elbow flexors strength after isometric exercise at long muscle length. J Sports Sci 2003;21: 859-65.
5. Philippou A, Bogdanis GC, Nevill AM, Maridaki M. Changes in the angle-force curve of human elbow flexors following eccentric and isometric exercise. Eur J Appl Physiol 2004;93:237-44.
6. Jones DA, Newham DJ, Round JM, Tolfree SE. Experimental human muscle damage: morphological changes in relation to other indices of damage. J Physiol 1986; 375:435-48.
7. Sorichter S, Puschendorf B, Mair J. Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exerc Immunol Rev 1999;5:5-21.
8. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005; 288:R345-53.
9. Hellsten Y, Frandsen U, Orthenblad N, Sjodin B, Richter EA. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. J Physiol 1997;498(Pt 1):239-48.
10. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio M, et al. Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 2002;283:C289-95.
11. Peake J, Nosaka K, Suzuki K. Characterization of inflammatory responses to eccentric exercise in humans. Exerc Immunol Rev 2005;11:64-85.
12. Prasartwuth O, Taylor JL, Gandevia SC. Maximal force, voluntary activation and muscle soreness after eccentric damage to human elbow flexor muscles. J Physiol 2005;567:337-48.
13. Mourkioti F, Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol 2005;26:535-42.
14. Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 2002;81:S52-69.
15. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112:321S-9S.
16. Smith LL, Anwar A, Fragen M, Rananto C, Johnson R, Holbert D. Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise. Eur J Appl Physiol 2000;82:61-7.
17. Cavaillon JM. Cytokines and macrophages. Biomed Pharmacother 1994;48:445-53.
18. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000;80:1055-81.
19. Lorenzo J. Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest 2000;106:749-52.
20. Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M. Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004;94:239-46.
21. Brockett CL, Morgan DL, Proske U. Human hamstring muscles adapt to eccentric exercise by changing optimum length. Med Sci Sports Exerc 2001;33:783-90.
22. Nosaka K, Clarkson PM. Variability in serum creatine kinase response after eccentric exercise of the elbow flexors. Int J Sports Med 1996;17:120-7.
23. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004;84: 209-38.
24. Pedersen BK, Steensberg A, Schjerling P. Musclederived interleukin-6: possible biological effects. J Physiol 2001;536:329-37.
25. Jonsdottir IH, Schjerling P, Ostrowski K, Asp S, Richter EA, Pedersen BK. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 2000;528(Pt 1):157-63.
26. Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol 2000;83:512-5.
27. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001; 537:633-9.
28. Malm C. Exercise-induced muscle damage and inflammation: fact or fiction? Acta Physiol Scand 2001; 171:233-9.
29. Saidenberg Kermanac'h N, Bessis N, Cohen-Solal M, De Vernejoul MC, Boissier MC. Osteoprotegerin and inflammation. Eur Cytokine Netw 2002;13:144-53.
30. Halapas A, Zacharoulis A, Theocharis S, Karavidas A, Korres D, Papadopoulos K, et al. Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction. Clin Chem Lab Med 2008;46:510-6.
31. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18:428-32.
32. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-20.